Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | TEVA | RDY | BBIO | BHC |
| Company | Cymabay Therapeutics | Teva Pharmaceutical Industries ADR | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 32.49 | 16.52 | 76.56 | 25.02 | 7.11 |
| High | 32.50 | 16.67 | 76.63 | 25.22 | 7.15 |
| Low | 32.48 | 16.41 | 76.06 | 24.71 | 7.09 |
| Last | 32.48 | 16.65 | 76.54 | 25.41 | 7.16 |
| Change | +0.01 | +0.10 | +0.42 | +0.50 | +0.05 |
| % Change | +0.03% | +0.60% | +0.55% | +2.01% | +0.70% |
| Volume | 8,356,200 | 697,370 | 5,665 | 44,538 | 188,371 |
| 20-Day Average Volume | 3,390,805 | 8,500,922 | 254,289 | 2,682,456 | 2,117,487 |
| Previous Close | 32.47 | 16.55 | 76.12 | 24.91 | 7.11 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 16.78 | 72.62 | 26.39 | 6.60 |
| 20-Day Raw Stochastic | 94.12% | 45.41% | 96.03% | 43.01% | 95.45% |
| 20-Day Relative Strength | 78.00% | 54.20% | 64.68% | 42.83% | 53.77% |
| Weighted Alpha | +247.60 | +107.62 | +21.90 | -16.21 | -17.64 |
| Today's Opinion | 100% Buy | 80% Buy | 56% Buy | 100% Sell | 40% Sell |
| Previous Opinion | 100% Buy | 80% Buy | 56% Buy | 100% Sell | 40% Sell |
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Sell | 24% Sell | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | +1.91% since 06/26/24 | +6.25% since 06/26/24 | +5.86% since 06/26/24 | +4.57% since 06/26/24 |
| Low | 32.44 on 03/15/24 | 15.62 on 07/01/24 | 73.38 on 06/27/24 | 23.22 on 06/27/24 | 6.68 on 06/27/24 |
| High | 32.50 on 03/21/24 | 16.62 on 07/02/24 | 76.83 on 06/28/24 | 26.10 on 07/01/24 | 7.15 on 07/03/24 |
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -2.47% since 06/03/24 | +10.19% since 06/03/24 | -13.94% since 06/03/24 | +12.16% since 06/03/24 |
| Low | 32.15 on 02/22/24 | 15.62 on 07/01/24 | 68.43 on 06/04/24 | 21.62 on 06/24/24 | 6.05 on 06/14/24 |
| High | 32.50 on 03/21/24 | 17.69 on 06/12/24 | 76.83 on 06/28/24 | 31.43 on 06/04/24 | 7.15 on 07/03/24 |
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | +17.28% since 04/03/24 | +4.81% since 04/03/24 | -14.68% since 04/03/24 | -29.28% since 04/03/24 |
| Low | 22.11 on 01/26/24 | 12.51 on 04/19/24 | 68.07 on 05/31/24 | 21.62 on 06/24/24 | 6.05 on 06/14/24 |
| High | 32.50 on 03/21/24 | 17.69 on 06/12/24 | 76.83 on 06/28/24 | 31.43 on 06/04/24 | 10.48 on 04/05/24 |
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | +51.23% since 01/03/24 | +8.54% since 01/03/24 | -34.11% since 01/03/24 | -9.09% since 01/03/24 |
| Low | 12.32 on 10/13/23 | 10.75 on 01/05/24 | 67.16 on 01/17/24 | 21.62 on 06/24/24 | 6.05 on 06/14/24 |
| High | 32.50 on 03/21/24 | 17.69 on 06/12/24 | 77.72 on 02/23/24 | 41.04 on 02/15/24 | 11.46 on 04/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 18,745,208 | 12,703,896 | 4,661,383 | 2,566,639 |
| Shares Outstanding, K | 114,724 | 1,132,641 | 166,893 | 187,129 | 360,990 |
| Annual Sales | 31,070,000 | 15,846,000,000 | 3,350,000,000 | 9,300,000 | 8,757,000,000 |
| Annual Net Income | -105,370,000 | -559,000,000 | 668,000,000 | -643,200,000 | -592,000,000 |
| Last Quarter Sales | 60,000 | 3,819,000,000 | 835,080,000 | 211,120,000 | 2,153,000,000 |
| Last Quarter Net Income | -41,900,000 | -139,000,000 | 153,390,000 | -35,220,000 | -64,000,000 |
| 60-Month Beta | 0.32 | 0.90 | 0.55 | 1.06 | 0.77 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.48 on 05/08/24 | 0.94 on 05/07/24 | -0.05 on 05/02/24 | 0.59 on 05/02/24 |
| Latest Earnings Date | 03/21/24 | 08/07/24 | 07/24/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | 0.410 on 07/28/23 | N/A | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 11/27/17 | 07/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 18.71 | 0.00 | 1.98 |